Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cancer diagnostics
MedTech
FDA approves next-gen PSA test from Cleveland Diagnostics
The IsoPSA blood test looks for specific variants of the PSA protein that can be linked to higher risks of malignant disease.
Conor Hale
Dec 3, 2025 10:05am
Guardant blood test gives early warning of cancer progression
Nov 10, 2025 8:15am
Grail reveals boosted performance data from cancer blood test
Oct 20, 2025 8:40am
Foundation Medicine awards new grant for biommarker testing push
Oct 6, 2025 8:45am
AZ outlines AI-enabled TROP2 biomarker strategy for Daiichi ADC
Sep 8, 2024 12:22pm
Paige and Microsoft roll out updated AI models to detect cancer
Aug 12, 2024 7:15am
